BHS Webinar supported by AstraZeneca
Cardio-Oncology in CLL: Uniting the Hematologist's and the Cardio-oncologists's Presepective
PROGRAMME
Chair & moderation : Prof. Dr. Ann Janssens (UZ Leuven)
- 19:00 Introductions and goal of the webinar
Prof. Dr. Ann Janssens (UZ Leuven)
- 19:05-19:20 The cardiovascular safety profile of BTKi-based treatments in the CLL patient population: Insights from a hematologist
Dr Lindsey Roeker (Memorial Sloan Kettering Cancer Center, US)
- 19:20-19:30 Enhancing coardiovascular safety in CLL: A cardio-oncologist's view
Dr. Rupal O'Quinn (Penn Medicine, US)
- 19:30-19:40 Case discussion: uniting perspectives
Dr Roeker and Dr O'Quinn
- 19:40-20:00 Panel discussion and closing
Dr Lindsey Roeker, Dr. Rupal O'Quinn, Prof Dr Lucas Aelst (UZ Leuven)